Kisqali Femara Co-Pack 200 mg-2.5 mg Dose and Sarilumab Subcutaneous
Determining the interaction of Kisqali Femara Co-Pack 200 mg-2.5 mg Dose and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Sarna Hc Topical application
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Sarnol-HC
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Sarnol-HC Maximum Strength
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-SAStid
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Sastid Soap Topical
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-SAStid Topical
- Sarilumab Subcutaneous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Sarilumab Subcutaneous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Sarilumab Subcutaneous-Kitabis Pak
- Sarilumab Subcutaneous-Kitabis Pak inhalation
- Sarilumab Subcutaneous-Klofensaid II
- Sarilumab Subcutaneous-Klonopin